Jean Tsai, MD - Medicare Neurology in Aurora, CO

Jean Tsai, MD is a medicare enrolled "Psychiatry & Neurology - Neurology" physician in Aurora, Colorado. She went to Perelman School Of Med At The University Of Pennsylvania and graduated in 2003 and has 21 years of diverse experience with area of expertise as Neurology. She is a member of the group practice University Physicians Incorporated and her current practice location is 12605 E 16th Ave, Aurora, Colorado. You can reach out to her office (for appointments etc.) via phone at (720) 848-0000.

Jean Tsai is licensed to practice in Colorado (license number 47277) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1679638829.

Contact Information

Jean Tsai, MD
12605 E 16th Ave,
Aurora, CO 80045-2545
(720) 848-0000
Not Available



Physician's Profile

Full NameJean Tsai
GenderFemale
SpecialityNeurology
Experience21 Years
Location12605 E 16th Ave, Aurora, Colorado
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Jean Tsai attended and graduated from Perelman School Of Med At The University Of Pennsylvania in 2003
  NPI Data:
  • NPI Number: 1679638829
  • Provider Enumeration Date: 12/27/2006
  • Last Update Date: 01/28/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 9537222047
  • Enrollment ID: I20090109000386

Medical Identifiers

Medical identifiers for Jean Tsai such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1679638829NPI-NPPES
91075041MedicaidCO

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084N0400XPsychiatry & Neurology - Neurology 47277 (Colorado)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
University Of Colorado Hospital AuthorityAurora, COHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Physicians Incorporated34764656672657

News Archive

Obese pregnant women have greater risk of early and late-onset hypertensive disorders

Pregnant obese women were more at risk of experiencing early and late-onset hypertensive disorders, and that risk progressively increased in women with higher body mass indexes (BMI), according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).

Palatin Technologies to announce clinical trial results of PL-3994

Palatin Technologies, Inc. (NYSE Amex: PTN) announced that a poster on clinical trial results with PL-3994, its product for heart failure, will be presented today at the 13th Annual Scientific Meeting of the Heart Failure Society of America in Boston.

New brain tumor research could improve patient diagnosis, treatment options

New research on brain tumours could improve patient diagnosis and treatment options as part of a precision medicine approach. Brain tumours are the leading cause of cancer deaths in children and adults under the age of 40, with 16,000 people in the UK diagnosed with a brain tumour each year.

Genervon's GM604 bio-drug receives FDA orphan drug designation for ALS treatment

Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.

SORT-OUT IV trial compares XIENCE V, CYPHER Stent in major acute coronary events

Investigators reported results of SORT-OUT IV, comparing Cordis Corporation's CYPHER Sirolimus-eluting Coronary Stent and Abbott's XIENCE V Everolimus-eluting Stent in the primary endpoint of MACE (major acute coronary events) at nine months.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jean Tsai allows following entities to bill medicare on her behalf.
Entity NameDenver Health And Hospital Authority
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1477569838
PECOS PAC ID: 4688583578
Enrollment ID: O20031105000211

News Archive

Obese pregnant women have greater risk of early and late-onset hypertensive disorders

Pregnant obese women were more at risk of experiencing early and late-onset hypertensive disorders, and that risk progressively increased in women with higher body mass indexes (BMI), according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).

Palatin Technologies to announce clinical trial results of PL-3994

Palatin Technologies, Inc. (NYSE Amex: PTN) announced that a poster on clinical trial results with PL-3994, its product for heart failure, will be presented today at the 13th Annual Scientific Meeting of the Heart Failure Society of America in Boston.

New brain tumor research could improve patient diagnosis, treatment options

New research on brain tumours could improve patient diagnosis and treatment options as part of a precision medicine approach. Brain tumours are the leading cause of cancer deaths in children and adults under the age of 40, with 16,000 people in the UK diagnosed with a brain tumour each year.

Genervon's GM604 bio-drug receives FDA orphan drug designation for ALS treatment

Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.

SORT-OUT IV trial compares XIENCE V, CYPHER Stent in major acute coronary events

Investigators reported results of SORT-OUT IV, comparing Cordis Corporation's CYPHER Sirolimus-eluting Coronary Stent and Abbott's XIENCE V Everolimus-eluting Stent in the primary endpoint of MACE (major acute coronary events) at nine months.

Read more Medical News

› Verified 1 days ago

Entity NameUniversity Physicians Incorporated
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1962461889
PECOS PAC ID: 3476465667
Enrollment ID: O20031105000375

News Archive

Obese pregnant women have greater risk of early and late-onset hypertensive disorders

Pregnant obese women were more at risk of experiencing early and late-onset hypertensive disorders, and that risk progressively increased in women with higher body mass indexes (BMI), according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).

Palatin Technologies to announce clinical trial results of PL-3994

Palatin Technologies, Inc. (NYSE Amex: PTN) announced that a poster on clinical trial results with PL-3994, its product for heart failure, will be presented today at the 13th Annual Scientific Meeting of the Heart Failure Society of America in Boston.

New brain tumor research could improve patient diagnosis, treatment options

New research on brain tumours could improve patient diagnosis and treatment options as part of a precision medicine approach. Brain tumours are the leading cause of cancer deaths in children and adults under the age of 40, with 16,000 people in the UK diagnosed with a brain tumour each year.

Genervon's GM604 bio-drug receives FDA orphan drug designation for ALS treatment

Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.

SORT-OUT IV trial compares XIENCE V, CYPHER Stent in major acute coronary events

Investigators reported results of SORT-OUT IV, comparing Cordis Corporation's CYPHER Sirolimus-eluting Coronary Stent and Abbott's XIENCE V Everolimus-eluting Stent in the primary endpoint of MACE (major acute coronary events) at nine months.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jean Tsai is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jean Tsai, MD
Po Box 110429,
Aurora, CO 80042-0429

Ph: (303) 493-7000
Jean Tsai, MD
12605 E 16th Ave,
Aurora, CO 80045-2545

Ph: (720) 848-0000

News Archive

Obese pregnant women have greater risk of early and late-onset hypertensive disorders

Pregnant obese women were more at risk of experiencing early and late-onset hypertensive disorders, and that risk progressively increased in women with higher body mass indexes (BMI), according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).

Palatin Technologies to announce clinical trial results of PL-3994

Palatin Technologies, Inc. (NYSE Amex: PTN) announced that a poster on clinical trial results with PL-3994, its product for heart failure, will be presented today at the 13th Annual Scientific Meeting of the Heart Failure Society of America in Boston.

New brain tumor research could improve patient diagnosis, treatment options

New research on brain tumours could improve patient diagnosis and treatment options as part of a precision medicine approach. Brain tumours are the leading cause of cancer deaths in children and adults under the age of 40, with 16,000 people in the UK diagnosed with a brain tumour each year.

Genervon's GM604 bio-drug receives FDA orphan drug designation for ALS treatment

Genervon Biopharmaceuticals announced today that the U.S. Food and Drug Administration has granted an "orphan drug" designation to Genervon's GM604 (a.k.a. GM6) bio-drug for the treatment of Amyotrophic Lateral Sclerosis (ALS). The FDA also granted GM604 a "fast-track" designation for ALS in 2013.

SORT-OUT IV trial compares XIENCE V, CYPHER Stent in major acute coronary events

Investigators reported results of SORT-OUT IV, comparing Cordis Corporation's CYPHER Sirolimus-eluting Coronary Stent and Abbott's XIENCE V Everolimus-eluting Stent in the primary endpoint of MACE (major acute coronary events) at nine months.

Read more News

› Verified 1 days ago


Psychiatry & Neurology Doctors in Aurora, CO

Lea C Watson, MD
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 1890 N Revere Ct, Aurora, CO 80045
Phone: 720-848-0000    
Robert House, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 12605 E 16th Ave, Aurora, CO 80045
Phone: 720-848-0000    
Ann Olincy, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 12605 E 16th Ave, Aurora, CO 80045
Phone: 720-848-0000    
Paul Moe, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 13123 E 16th Ave, Aurora, CO 80045
Phone: 720-777-1234    
Dr. Erin Schwarz, D.O.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 1537 Alton St, Aurora, CO 80010
Phone: 303-617-2300    
Robert Clyman, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 13123 E 16th Ave, Aurora, CO 80045
Phone: 720-777-1234    
Dr. Bishara Bhasi, MD
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: 13123 E 16th Ave, Aurora, CO 80045
Phone: 720-848-0000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.